Search Results

PPD FSP regulatory affairs solutions help navigate regulatory approval and market access with comprehensive end-to-end regulatory services.

Learn how using RWD and RWE to supplement trials provides understanding of safety and efficacy and effective off-label use.

Biopharmaceutical companies are needing more and more evidence to prove value and effectiveness in post-approval settings, including how to communicate this evidence to payers, health authorities and other decision-makers.

Learn more about the capabilities PPD Laboratory Services’ GMP lab offers to meet customers’ needs from cell-based assays to stability testing.

Discover how Regulatory Intelligence is used in the pharmaceutical product development process through helping to formulate clinical trial success.

Learn more about the increased uptake of Emergency Use Authorizations (EUA) for medical devices during the COVID-19 pandemic.

Learn the importance of strategy formulation and regulatory engagement for planning a successful ISS/ISE submission.

PPD experts discuss advances for eCTD implementation in mainland China and Taiwan and detail three critical success factors for readiness.

Researchers incorporating wearables into their work should think of them as complementing — rather than replacing — insights from PROs.